captopril has been researched along with leptin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharadwaj, K; Boustany, CM; Cassis, LA; English, VL | 1 |
| Brooks, AN; Gardner, DS; Gopalakrishnan, GS; Keisler, DH; Kyle, CE; Rae, MT; Ramsay, MM; Rhind, SM; Stephenson, T; Symonds, ME; Walker, RM | 1 |
| Bergamaschi, CT; Campos, RR; Carillo, BA; Carmona, AK; Casarini, DE; Dolnikoff, MS; Freitas, RR; Furukawa, L; Heimann, JC; Lopes, KL | 1 |
| Al-Saleh, FM; Benter, IF; Chappell, MC; Diz, DI; Raghupathy, R; Yousif, MH | 1 |
| Begg, DP; Cameron-Smith, D; Hafandi, A; Jois, M; Manickam, E; Premaratna, SD; Rayment, DJ; Weisinger, RS | 1 |
| Brooks, L; Dellsperger, D; Grobe, JL; Hilzendeger, AM; Liu, X; Mark, AL; Morgan, DA; Rahmouni, K; Sigmund, CD | 1 |
| Bult, H; Herijgers, P; Mubagwa, K; Nevelsteen, I; Van den Bergh, A; Van der Mieren, G; Vanderper, A | 1 |
| Balam-Salazar, LB; Cardona-Muñoz, EG; Curiel-Beltrán, JA; de Jesús Romero-Prado, MM; Miramontes-Espino, MV; Rios-Arellano, A | 1 |
| Ciriello, J; Messenger, SA; Moreau, JM | 1 |
1 trial(s) available for captopril and leptin
| Article | Year |
|---|---|
Dietary flavonoids added to pharmacological antihypertensive therapy are effective in improving blood pressure.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; C-Reactive Protein; Cacao; Candy; Captopril; Combined Modality Therapy; Diet; Female; Flavonoids; Fruit; Humans; Hypertension; Leptin; Lipids; Male; Malus; Mexico; Middle Aged; Tea; Telmisartan; Time Factors; Treatment Outcome; Young Adult | 2015 |
8 other study(ies) available for captopril and leptin
| Article | Year |
|---|---|
Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Leptin; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sympathetic Nervous System; Vasoconstrictor Agents | 2004 |
Programming of adult cardiovascular function after early maternal undernutrition in sheep.
Topics: Algorithms; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Birth Weight; Blood Glucose; Blood Pressure; Body Composition; Captopril; Female; Heart Rate; Hemodynamics; Hormones; Hydrocortisone; Leptin; Male; Norepinephrine; Placental Insufficiency; Pregnancy; Prenatal Exposure Delayed Effects; Sheep; Stress, Physiological; Vasoconstrictor Agents | 2004 |
Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Blood Pressure; Body Weight; Captopril; Cardiac Output; Dietary Sucrose; Hexamethonium; Hypertension; Insulin; Kidney; Leptin; Male; Random Allocation; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Sodium; Sympathetic Nervous System; Vascular Resistance | 2007 |
Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Brain; Captopril; Cytokines; Heart; Hydralazine; Hypertension; In Vitro Techniques; Insulin; Kidney; Leptin; Male; Myocardial Contraction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Perfusion; Proteinuria; Rats; Rats, Inbred SHR; Ventricular Function, Left | 2011 |
Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Adiponectin; Adipose Tissue; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Body Weight; Captopril; Chemokine CCL2; Diet, High-Fat; Gene Expression Regulation; Glucose Tolerance Test; Inflammation; Insulin Resistance; Interleukin-6; Ion Channels; Leptin; Lipid Metabolism; Lipoprotein Lipase; Male; Mice; Mice, Inbred C57BL; Mitochondrial Proteins; Muscle, Skeletal; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Sterol Esterase; Toll-Like Receptor 4; Trans-Activators; Transcription Factors; Uncoupling Protein 2 | 2012 |
A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity.
Topics: Adipose Tissue; alpha-MSH; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Brain; Captopril; Corticotropin-Releasing Hormone; Eating; Gene Deletion; Leptin; Losartan; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sympathetic Nervous System | 2012 |
NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Blood Glucose; Caloric Restriction; Captopril; Combined Modality Therapy; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Dyslipidemias; Endothelium, Vascular; Female; Hypertension; Leptin; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Nitric Oxide; Receptors, LDL; Time Factors; Vasodilation; Vasodilator Agents; Weight Loss | 2013 |
Effects of angiotensin II on leptin and downstream leptin signaling in the carotid body during acute intermittent hypoxia.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Captopril; Carotid Body; Hypoxia, Brain; Leptin; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, Leptin; Signal Transduction | 2015 |